AGEN: Agenus O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Agenus antibody sintezi uchun yuqori xarajatlar va onkologiya segmentidagi bosimga duch kelmoqda, shunga qaramay, u o'z patentlarini yirik hamkorlardan olinadigan royalti to'lovlari orqali monetizatsiya qilmoqda. P/E koeffitsiyentini o'sish sur'atlari bilan solishtirish ushbu muvozanatni vizuallashtiradi, bunda 0.00 oxirgi metrika qiymatini aks ettiradi. Chiqindilardan foydalanishning izchil nazorati va markazning energiya samaradorligi biznesning uzoq muddatli barqarorligini qo'llab-quvvatlaydi.
Agenus (AGEN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Agenus|AGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi agenusbio.com|AGEN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Agenus Inc|AGEN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Agenus|Kritik likvidlik agenusbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AGEN - Sof foyda|Kutilayotgan sof foyda Agenus|AGEN - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Agenus, Inc|AGEN - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Agenus Inc|AGEN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Agenus|AGEN - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi agenusbio.com|AGEN - Joriy yilda foyda o'sishi|Keyingi yil uchun bitta aksiya uchun sof foyda o'sishi prognozi Agenus
Kompaniyaning umumiy tahlili:AGEN - Agenus, Inc.
Fundamental barqarorlik omillarini aniqlash uchun PEG koeffitsienti qo'llaniladi, bunda birdan past qiymatlar aktivning qadr-qimmati past baholanganligidan dalolat beradi. O'sishga nisbatan past baholanganlikning ushbu ko'rsatkichi tahlil qilingan holda, investor Agenus (AGEN) kompaniyasining o'z vaksinalarini tijoratlashtirish istiqbollari va immuno-onkologiya sohasidagi sherikliklardan tushadigan daromadlarini hisobga olgan holda, uning bozor qiymatining adolatli ekanligini baholaydi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|ABCL: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati tourmalinebio.com TRML|PGEN (Precigen) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pharming Group NV PHAR|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|Upstream Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Zenas Biopharma Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori immunome.com IMNM|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharma KALV|SEPN: PEG multiplikatori|Pieris Corp (PVLA) - PEG multiplikatori|SVRA (Savara Inc.) - PEG multiplikatori|RIGL - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori ANAB|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ACRS|KYTX: PEG multiplikatori|Tiziana Life Sciences Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|PEG multiplikatori Ventyx Biosciences, Inc|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|AVTX (avalotx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|CLYM - Narx-foyda va o‘sish multiplikatori|Zura Bio Limited - PEG multiplikatori|ATYR - PEG multiplikatori|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|Ikena Oncology - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|STTK (Shattuck Labs Inc) - PEG multiplikatori|Equillium Bio (EQ) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|Narx-foyda va o‘sish multiplikatori immunic-therapeutics.com IMUX|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|IFRX - Narx-foyda va o‘sish multiplikatori|XFOR: Narx-foyda va o‘sish multiplikatori|ACET - PEG multiplikatori|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti INMB|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda kezarlifesciences.com KZR|PEG multiplikatori SABS|PEG multiplikatori Akari Therapeutics PLC (AKTX)|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Narxning sof foyda o‘sishiga nisbati Q32 Bio Inc|GeoVax Labs, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda edesabiotech.com|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CARM|Narx-foyda va o‘sish multiplikatori XTLB|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aptevotherapeutics.com|PEG multiplikatori AIM (AIM ImmunoTech)|PEG multiplikatori Aditxt Inc. ADTX|GRI Bio Corp - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati XORTX Corp (XRTX)|HIND: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revbiosciences.com (REVB)|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti SCNI (Scinai Immunotherapeutics Ltd)|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|AFMD: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ALLK (Allakos)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti HOOK|IGM Bio - PEG multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
